Myocarditis after BNT162b2 and mRNA-1273 COVID-19 vaccination: A report of 7 cases.

ABSTRACT:

Background and objectives

According to some reports, there is a link between the development of myocarditis and the administration of messenger RNA (mRNA) vaccines against coronavirus disease (COVID-19). Here, we report seven cases that developed myocarditis after receiving a second dose of mRNA COVID-19 vaccine.

Methods

This is a multi-center case series study. In this study, we present 7 patients diagnosed with myocarditis following BNT162b2 and mRNA-1273 COVID-19 vaccinations on March 7, 2021, and March 3, 2022.

Results

All seven patients were males and hemodynamically stable. The median age was 24.5 years, ranging from 16 to 36 years old. All patients received the second dose of a messenger RNA (mRNA) vaccine between one and four days before being admitted to the

SUBMITTER: Ahmed SK 

PROVIDER: S-EPMC9021031 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature